| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/AJT.13025 |
| P698 | PubMed publication ID | 25648766 |
| P2093 | author name string | M Liedtke | |
| M Wheeler | |||
| M K Davis | |||
| S Arai | |||
| P Kale | |||
| S Schrier | |||
| R Lafayette | |||
| R M Witteles | |||
| T Coakley | |||
| P2860 | cites work | Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy. | Q53439106 |
| Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy. | Q53463848 | ||
| Electrophysiologic evaluation of the cardiac conduction system and its autonomic regulation in familial amyloid polyneuropathy. | Q53760952 | ||
| Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients. | Q54129778 | ||
| High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis | Q57218202 | ||
| Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival | Q58853078 | ||
| Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure | Q34240595 | ||
| Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. | Q35002777 | ||
| Long term results of heart transplantation in patients with amyloid heart disease | Q35378115 | ||
| Evaluation and management of the cardiac amyloidosis. | Q37013270 | ||
| Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis | Q37624857 | ||
| Amyloid diseases of the heart: assessment, diagnosis, and referral | Q37819545 | ||
| Light-chain amyloidosis: SCT, novel agents and beyond | Q38056010 | ||
| Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure | Q42166191 | ||
| Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis. | Q43050098 | ||
| The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report--2013; focus theme: age. | Q43587073 | ||
| Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS). | Q44545593 | ||
| Cardiac transplantation for amyloid heart disease: the United Kingdom experience | Q45101029 | ||
| Left ventricular device implantation for advanced cardiac amyloidosis | Q45299740 | ||
| Outcomes of adults with restrictive cardiomyopathy after heart transplantation | Q46298655 | ||
| Heart transplantation for homozygous familial transthyretin (TTR) V122I cardiac amyloidosis. | Q46719529 | ||
| Outcomes of heart transplantation for cardiac amyloidosis: subanalysis of the spanish registry for heart transplantation | Q47751835 | ||
| Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategies. | Q50996007 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Amyloid cardiomyopathy | Q4749546 |
| P304 | page(s) | 650-658 | |
| P577 | publication date | 2015-02-03 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Outcomes after heart transplantation for amyloid cardiomyopathy in the modern era. | |
| P478 | volume | 15 |
| Q39217713 | Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis |
| Q92858052 | Approach to a patient with cardiac amyloidosis |
| Q92218771 | Cardiac Amyloid - An Update |
| Q39320411 | Cardiac Amyloidosis: Diagnosis and Treatment Strategies |
| Q98161293 | Diagnosis and treatment of transthyretin-related amyloidosis cardiomyopathy |
| Q26776496 | Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis |
| Q42226402 | Different patterns of left ventricular rotational mechanics in cardiac amyloidosis-results from the three-dimensional speckle-tracking echocardiographic MAGYAR-Path Study |
| Q39172346 | Heart transplantation in cardiac amyloidosis |
| Q38928383 | Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment |
| Q37035201 | Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experience |
| Q38920614 | Newer Therapies for Amyloid Cardiomyopathy |
| Q99361678 | Outcomes of Heart Transplantation in Cardiac Amyloidosis Patients: A Single Center Experience |
| Q47769560 | Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy |
| Q42377785 | Sequential heart and autologous stem cell transplantation for light-chain cardiac amyloidosis |
| Q30244227 | Transthyretin Cardiac Amyloidosis in Older Americans |
Search more.